Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Severe Aortic Stenosis
ClinicalTrials.gov study NCT03471065. IPD Sharing: NO. Countries: 2. Publications: 0.
Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure
ClinicalTrials.gov study NCT02159872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects
ClinicalTrials.gov study NCT03618095. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
ClinicalTrials.gov study NCT02770391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
ClinicalTrials.gov study NCT01011283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
ClinicalTrials.gov study NCT01980056. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
ClinicalTrials.gov study NCT06499285. IPD Sharing: YES. Countries: 25. Publications: 0.
Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia
ClinicalTrials.gov study NCT02335268. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
ClinicalTrials.gov study NCT03670030. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00458159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC
ClinicalTrials.gov study NCT04843943. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT04419649. IPD Sharing: YES. Countries: 8. Publications: 0.
Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia
ClinicalTrials.gov study NCT03215043. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
ClinicalTrials.gov study NCT01342367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
ClinicalTrials.gov study NCT01985828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
ClinicalTrials.gov study NCT01891968. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
ClinicalTrials.gov study NCT03315754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
ClinicalTrials.gov study NCT02922179. IPD Sharing: YES. Countries: 0. Publications: 2.
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT02280356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis
ClinicalTrials.gov study NCT03517436. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.